Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
HIV InfectionsAIDS
Interventions
DRUG

stavudine, efavirenz, lamivudine

Trial Locations (63)

Unknown

Local Institution, Berkeley

Local Institution, Los Angeles

Local Institution, West Hollywood

Local Institution, Washington D.C.

Local Institution, Fort Lauderdale

Local Institution, Orlando

Local Institution, Tampa

Local Institution, Indianapolis

Local Institution, Wichita

Local Institution, Louisville

Local Institution, Brookline

Local Institution, Las Vegas

Local Institution, Reno

Local Institution, New York

Local Institution, Winston-Salem

Local Institution, Oklahoma City

Local Institution, Dallas

Local Institution, Houston

Local Institution, Hampton

Local Institution, San Isidro

Local Institution, Rosario

Local Institution, Buenos Aires

Local Institution, Córdoba

Local Institution, Ghent

Local Institution, Liège

Local Institution, Salvador

Local Institution, Belo Horizonte - MG

Local Institution, Botucatu

Local Institution, Santos

Local Institution, Vancouver

Local Institution, Toronto

Local Institution, Montreal

Local Institution, Bordeaux

Local Institution, Lyon

Local Institution, Nantes

Local Institution, Paris

Local Institution, Rennes

Local Institution, Rehovot

Local Institution, Tel Hashorner

Local Institution, Bari

Local Institution, Bergamo

Local Institution, Florence

Local Institution, Milan

Local Institution, Napoli

Local Institution, Pisa

Local Institution, Torino

Local Institution, Mexico City

Local Institution, Coimbra

Local Institution, Lisbon

Local Institution, Cotto Laurel

Local Institution, San Juan

Local Institution, Moscow

Local Institution, Saint Petersburg

Local Institution, Singapore

Local Institution, Bedford Gardens

Local Institution, Hatfield

Local Institution, Johannesburg

Local Institution, Westdene

Local Institution, Tygerberg

Local Institution, Barcelona

Local Institution, Madrid

Local Institution, Bangkok

Local Institution, Nontaburi

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00116298 - Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) | Biotech Hunter | Biotech Hunter